Nisa Investment Advisors
PSTX

Nisa Investment Advisors’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Nisa Investment Advisors’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-329
Closed -$3.16K – 3092
2024
Q4 		$3.16K Buy
329
+48
+17% +$250 ﹤0.01% 2380
2024
Q3 		$804 Buy
281
+195
+227% +$604 ﹤0.01% 2625
2024
Q2 		$251 Buy
86
+9
+12% +$25 ﹤0.01% 2790
2024
Q1 		$246 Buy
77
+36
+88% +$120 ﹤0.01% 2610
2023
Q4 		$138 Buy
+41
New +$106 ﹤0.01% 2597
2022
Q2 		– Sell
-13,000
Closed -$58K – 2530
2022
Q1 		$58K Buy
+13,000
New +$58.6K ﹤0.01% 1798
2021
Q4 		– Sell
-600
Closed -$4 – 2339
2021
Q3 		$4 Buy
600
+300
+100% +$2.57K ﹤0.01% 2275
2021
Q2 		$3 Buy
+300
New +$2.69K ﹤0.01% 2297

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nisa Investment Advisors's PSTX Position: Q1 2025 in Review

Nisa Investment Advisors sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 329 shares — an estimated $3.16K sold.

Nisa Investment Advisors first reported a position in PSTX in Q2 2021 and held it in 8 quarters. The position peaked at $58K in Q1 2022. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • Nisa Investment Advisors reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 329 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $3.16K.
  • Nisa Investment Advisors first reported a position in Poseida Therapeutics, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Nisa Investment Advisors's Poseida Therapeutics, Inc. Common Stock position peaked at $58K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Nisa Investment Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.